{"id":"W3093890556","doi":"10.1016/j.lungcan.2020.10.008","title":"Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study","year":2020,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Biotech; Associazione Italiana per la Ricerca sul Cancro; MedImmune; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Eisai; Seattle Genetics; Merck KGaA; Daiichi Sankyo Europe; Sanofi; Novartis; Ipsen; British Mycological Society; Daiichi-Sankyo; United Therapeutics Corporation; MSD Life Science Foundation, Public Interest Incorporated Foundation; Bayer; Celgene; AstraZeneca; Roche; Astellas Pharma US; Pfizer; Boehringer Ingelheim","keywords":"Medicine; Internal medicine; Oncology; Lung cancer; Clinical endpoint; Chemotherapy; Immunotherapy; Retrospective cohort study; Confidence interval; Gemcitabine; Hazard ratio; Cancer; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007707952,0.0002809646,0.0003838862,0.00005152036,0.0001145294,0.000043233,0.0001544412,0.00008848199,0.000810365],"category_scores_gemma":[0.000009305838,0.0001889033,0.0001233797,0.0003362138,0.00004511982,0.0001052893,0.00004493342,0.0003863893,0.000007821972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001121484,"about_ca_system_score_gemma":0.0002424806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00324991,"about_ca_topic_score_gemma":0.001738284,"domain_scores_codex":[0.9984388,0.00005917315,0.0003233438,0.0005034401,0.0003136938,0.0003615734],"domain_scores_gemma":[0.9992293,0.00002743273,0.0001297816,0.0003244587,0.0001680282,0.0001209647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001095517,0.001059464,0.9644973,0.0001058088,0.0005448413,0.00001803262,0.02925375,0.00003070566,0.0002268753,0.000001049582,0.001266258,0.001900429],"study_design_scores_gemma":[0.01349008,0.0003428826,0.9813786,0.0001432324,0.0004506616,1.53951e-7,0.0005607091,0.001582332,0.000420382,0.000002030957,0.001424772,0.0002041239],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867907,0.003721689,0.00004286322,0.003988696,0.0004324618,0.004167477,0.00009353767,0.00004534205,0.0007172263],"genre_scores_gemma":[0.9890491,0.0005324755,0.00008176605,0.007152402,0.0003033948,0.001997469,0.00001351265,0.00006736803,0.0008024879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02869304,"threshold_uncertainty_score":0.8872928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007440933025061391,"score_gpt":0.3071473753137865,"score_spread":0.2997064422887251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}